Assistant Professor, Faculty of Medicine & Health Sciences
My research focuses on understanding the molecular and cell biology of the hypoxic microenvironment. Hypoxia (low oxygen) is key in many pathological settings including wound healing, inflammation, ischemia and cancer. Regions of hypoxia in tumours are associated with worse survival, chemotherapy and radiotherapy resistance. Tumour hypoxia arises from the combination of high metabolic and proliferative rates and aberrant vascularisation. The hypoxic tumour microenvironment is also acidic as metabolic acid accumulates in poorly-vascularised areas. Hypoxia induces a transcriptome shift under the regulation of the transcription factors HIF1α and HIF2α, which are stabilised in hypoxia. HIFs regulate genes in key "hallmarks of cancer" processes that enable adaptation to the hypoxic tumour microenvironment. In many cases anti-angiogenic therapy, such as bevacizumab, increases tumour hypoxia and hypoxic adaptation is a major mechanism of resistance to anti-angiogenic therapies. Understanding the molecular consequences of hypoxia and how to target hypoxic regions of tumours is key in improving tumour patient survival.
My research interests are:
Epigenetic regulation of gene expression
Invasion and metastasis
Functional shRNA/siRNA screens - Induced essentiality
Stem cell maintenance
Our work is generously funded by: Breast Cancer Now and Bowel & Cancer Research.
I have a Self-funded PhD studentship available please contact me directly to find out more details.
School of Medicine
The University of Nottingham
D Floor, West Block, Queen's Medical Centre
Nottingham, NG7 2UH
telephone: +44 (0) 115 82 31135
Connect with the University of Nottingham through social media and our blogs.
Campus maps | More contact information | Jobs
Browser does not support script.